NCT05605314 Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
| NCT ID | NCT05605314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Dry Eye |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Primary Sjögren's syndrome is a chronic autoimmune disease that primarily involves exocrine glands, most commonly manifested in dry eye, dry mouth, and in other systems of the body.
Eligibility Criteria
Inclusion Criteria: * All enrolled DED participants met the criterion of TFOS DEWS II Definition and Classification Report and pSS-DED group also met 2016ACR/EULAR pSS diagnosis and classification consensus. Exclusion Criteria: * (1) patients were diagnosed as any rheumatic or systematic diseases that would probably affect tear function except for pSS and DED. (2) had a history of ocular trauma or surgery. (3) had a history of wearing contact lens. (4) had concomitant ocular lesions such as acute inflammation or infection, glaucoma or eyelid abnormalities. (5) cannot cooperate properly or finish related examinations.
Contact & Investigator
Liyuan Tao, PhD
STUDY CHAIR
Peking University Third Hospital
Frequently Asked Questions
Who can join the NCT05605314 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Dry Eye. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05605314 currently recruiting?
Yes, NCT05605314 is actively recruiting participants. Contact the research team at superjune@sina.com for enrollment information.
Where is the NCT05605314 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05605314 clinical trial?
NCT05605314 is sponsored by Peking University Third Hospital. The principal investigator is Liyuan Tao, PhD at Peking University Third Hospital. The trial plans to enroll 500 participants.